no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Clioquinol: To harm or heal
|
Perez, Dominique R. |
|
2019 |
199 |
C |
p. 155-163 |
article |
2 |
Editorial Board
|
|
|
2019 |
199 |
C |
p. ii |
article |
3 |
Emerging drug development technologies targeting ubiquitination for cancer therapeutics
|
Veggiani, Gianluca |
|
2019 |
199 |
C |
p. 139-154 |
article |
4 |
Fast-acting antidepressant activity of ketamine: highlights on brain serotonin, glutamate, and GABA neurotransmission in preclinical studies
|
Pham, Thu Ha |
|
2019 |
199 |
C |
p. 58-90 |
article |
5 |
Gene-environment interactions in Alzheimer's disease: A potential path to precision medicine
|
Eid, Aseel |
|
2019 |
199 |
C |
p. 173-187 |
article |
6 |
Intestinal bacterial β-glucuronidase as a possible predictive biomarker of irinotecan-induced diarrhea severity
|
Chamseddine, Ali N. |
|
2019 |
199 |
C |
p. 1-15 |
article |
7 |
Intestinal microbiome as a novel therapeutic target for local and systemic inflammation
|
Uchiyama, Kazuhiko |
|
2019 |
199 |
C |
p. 164-172 |
article |
8 |
Limiting tumor seeding as a therapeutic approach for metastatic disease
|
Worrede, Asurayya |
|
2019 |
199 |
C |
p. 117-128 |
article |
9 |
Mast cell tryptase – Marker and maker of cardiovascular diseases
|
Mohajeri, Mohammad |
|
2019 |
199 |
C |
p. 91-110 |
article |
10 |
Potential biomarkers for persistent and neuropathic pain therapy
|
Sisignano, Marco |
|
2019 |
199 |
C |
p. 16-29 |
article |
11 |
Prevalence and role of HER2 mutations in cancer
|
Cocco, Emiliano |
|
2019 |
199 |
C |
p. 188-196 |
article |
12 |
Recent therapeutic trends and promising targets in triple negative breast cancer
|
Hwang, Soo-Yeon |
|
2019 |
199 |
C |
p. 30-57 |
article |
13 |
Super-enhancers in cancer
|
Thandapani, Palaniraja |
|
2019 |
199 |
C |
p. 129-138 |
article |
14 |
The emerging concept of “individualized cholesterol-lowering therapy”: A change in paradigm
|
Lütjohann, Dieter |
|
2019 |
199 |
C |
p. 111-116 |
article |